Ocugenix - Crunchbase Company Profile & Funding

Q: Who invested in Ocugenix?

Ocugenix is funded by Innovation Works.

Q: When was the last funding round for Ocugenix?

Ocugenix closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Ocugenix raised to date?

Ocugenix has raised obfuscated.

Overview

Ocugenix

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Ocugenix

CB Rank

109808

Ocugenix is a therapeutics company that develops treatments for angio-fibrotic diseases of the eye.

Founded

obfuscation

Private

Seed

Pittsburgh, Pennsylvania, United States

1-10

ocugenix.com

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Sean McDonald: President & CEO

Details

Legal Name

Ocugenix Corp.

Operating Status

Active

Company Type

For Profit

About the Company

Ocugenix is a therapeutics company focused on the development of cancer immunotherapy drugs intended to treat eye diseases. Its cancer immunotherapy drug is a medicine against drug-resistant bacteria, enabling doctors to perform a cancer-related eye treatment.

Phone Number

412-600-6379

Contact Email

info@ocugenix.com

Predictions & Insights

Growth Insight

See this Growth Insight

Ocugenix is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Phase 1 Ocular Indication Programs

Ocugenix is developing treatments for three specific eye conditions, currently in Phase 1 clinical trials.

CXCR3 Signaling Pathway Activation

A therapeutic approach targeting the CXCR3 signaling pathway to promote wound healing and prevent chronic inflammation, fibrosis, and scarring in the eye.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ocugenix	1	obfuscated obfuscation	—	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Innovation Works	—	Seed Round - Ocugenix	—
Innovation Works	—	Seed Round - Ocugenix	—
Innovation Works	—	Seed Round - Ocugenix	—
Innovation Works	—	Seed Round - Ocugenix	—
Innovation Works	—	Seed Round - Ocugenix	—